Regarding TBEV infection, differences in YKL-40 levels in CSF samples between patients with meningoencephalitis versus those with meningitis were proposed as a biomarker for the differentiation between clinical forms of TBE [79]. The gene discussed is CHI3L1; the disease is meningoencephalitis.